α-Synuclein is a Novel Microtubule Dynamase.

Vittorio Pandini, Graziella Cappelletti, Isabelle Arnal, Rita Grandori, Gianni Pezzoli, Laurent Roybon, Luigi Bubacco, Staffan Holmqvist, Stefano Pieraccini, Evelina Chieregatti, Marco Emanuele, Daniele Cartelli, Carmelita De Gregorio, Jacopo Marangon, Silvia Beltramone, Francesca Cantele, Francesca V M Casagrande, Enzio M Ragg, Carlo Santambrogio, Alberto Barbiroli, Alessandro Aliverti

Journal: Scientific reports 2018;6():33289

PMID: 27628239

Abstract

α-Synuclein is a presynaptic protein associated to Parkinson's disease, which is unstructured when free in the cytoplasm and adopts α helical conformation when bound to vesicles. After decades of intense studies, α-Synuclein physiology is still difficult to clear up due to its interaction with multiple partners and its involvement in a pletora of neuronal functions. Here, we looked at the remarkably neglected interplay between α-Synuclein and microtubules, which potentially impacts on synaptic functionality. In order to identify the mechanisms underlying these actions, we investigated the interaction between purified α-Synuclein and tubulin. We demonstrated that α-Synuclein binds to microtubules and tubulin α2β2 tetramer; the latter interaction inducing the formation of helical segment(s) in the α-Synuclein polypeptide. This structural change seems to enable α-Synuclein to promote microtubule nucleation and to enhance microtubule growth rate and catastrophe frequency, both in vitro and in cell. We also showed that Parkinson's disease-linked α-Synuclein variants do not undergo tubulin-induced folding and cause tubulin aggregation rather than polymerization. Our data enable us to propose α-Synuclein as a novel, foldable, microtubule-dynamase, which influences microtubule organisation through its binding to tubulin and its regulating effects on microtubule nucleation and dynamics.

Address: Dept. Biosciences, Università degli Studi di Milano, Milano, Italy.; Dept. of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Milano, Italy.; Dept. Biotecnology and Biosciences, Università degli Studi di Milano-Bicocca, Milano, Italy.; Dept. Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy.; Dept. Chemistry, Università degli Studi di Milano, Milano, Italy.; Stem Cell laboratory for CNS Disease Modeling, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund, Sweden.; Strategic Research Area MultiPark and Lund Stem Cell Center, Lund University, Lund, Sweden.; Dept. Biology, University of Padova, Padova, Italy.; Parkinson Institute, ASST G. Pini-CTO, ex ICP, Milano, Italy.; Grenoble Institut des Neurosciences, Grenoble, France.; Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.